Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Yeast Produce Malaria Drug Precursor

Researchers hope route will lead to a cost-effective approach to increasing supplies of artemisinin

by Celia Henry Arnaud
April 13, 2006

The total synthesis of the antimalarial drug artemisinin (bottom) is difficult and expensive, but synthesizing it from its immediate biosynthetic precursor, artemisinic acid (top), could be a cost-effective approach to increasing supplies of the drug.

Chemical engineering professor Jay D. Keasling and coworkers at the University of California, Berkeley, have engineered yeast to produce significant amounts (115 mg/L) of artemisinic acid (Nature 2006, 440, 940). They engineered the yeast in three steps. First, they manipulated the farnesyl pyrophosphate (FPP) biosynthetic pathway to increase production of FPP and prevent FPP from being used for sterol synthesis.

Then, they introduced a gene for amorphadiene synthase, which converts FPP to amorphadiene. Finally, they introduced a novel cytochrome P450 that performs a three-step oxidation of amorphadiene to artemisinic acid.

The engineered yeast produced much more quickly an amount of artemisinic acid that is comparable with the amount produced by the plant that usually makes it. Additional work will be required to optimize the yield and scale up the process.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.